Tegoyes 4.35mg/11.8mg/15mg Capsule
By Tegoyes
Rx
7 Capsule in a Strip

Composition
Gimeracil(4.35mg) + Oteracil(11.8mg) + Tegafur(15mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
August, 2025

liver
For individuals dealing with liver disease, it is important to note that Tegoyes 4.35mg/11.8mg/15mg Capsule can be safely used. It has been determined that no specific dosage adjustment of this medication is necessary for patients with liver conditions. This information indicates that Tegoyes 4.35mg/11.8mg/15mg Capsule can be utilized without many concerns regarding liver issues.

kidney
Tegoyes 4.35mg/11.8mg/15mg Capsule should be used carefully in patients with kidney disease. Adjusting the dosage might be necessary. It is important to consult your doctor regarding its use.

alcohol
Consult your doctor when consuming alcohol with Tegoyes 4.35mg/11.8mg/15mg Capsule.

driving
Tegoyes 4.35mg/11.8mg/15mg Capsule may cause side effects like fatigue, dizziness, blurred vision, and nausea, especially when used with cisplatin, which could impact driving ability.

pregnancy
Tegoyes 4.35mg/11.8mg/15mg Capsule should not be used during pregnancy as it poses risks to the developing baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Tegoyes 4.35mg/11.8mg/15mg Capsule should not be used while breastfeeding as it may harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹3600
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 18-Nov-2024